1Mogensen CE. Natural history of renal functional abnormalities in human diabetes mellitus: from normoalbuminuria to incipient and overt nephropathy. In:Brenner BM, Stein JH, ed. The Kidney in Diabetes Mellitus. New York:Churchill Livingstone 1989:19 - 49.
2Critchley JA, Zhao HL, Tomlinson B, et al. Management of nephropathy in patients with type 2 diabetes. Chin Med J (Engl)2002 ; 115(1 ) : 129 - 135.
3Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579 - 2588.
4Brownlee M. Biochemistry and molecular cellbiology of diabetic complications. Nature 2001 ;414:813 - 820.
5Kamiuchi K, Hasegawa G, Obayashi H, et al. Leukocyte - endothelialcell adhesion molecule 1 (LECAM- 1 ) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus. J Diabetes Complications 2002;16(5):333.
6The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin - dependent diabetes mellitus. N EnglJ Med 1993;329:977-86.
7UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications ( UKPDS33 ). Lancet 1998 ; 352 :837-853.
4Dolan E. Stanton A V. Thom S, et al. for ASCOT Investigators. Ambula- tory blood pressure monitoring predicts cardias outcomes trial substudy[J]. J Hypertens, 2009,27 (4) : 876 - 885.
5Burr ML, Dolan E, O Brien EW, et al. The value of ambulatory blood pressure in older adults: the Dublin outcome study[ J]. Age Ageing, 2008, 37(5) :201 - 206.
